Clinical Trial Update: Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating quetiapine for symptoms associated with Borderline Personality Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED